U.S. Household Products Stock News

Johnson & Johnson (JNJ) stock is in focus after FDA clearance of the MONARCH QUEST 3 bronchoscopy system, along with momentum in its Innovative Medicine segment despite ongoing STELARA biosimilar headwinds. See our latest analysis for Johnson & Johnson. At a share price of $262.37, Johnson & Johnson has a 90 day share price return of 14.07% and a year to date share price return of 26.53%. The 1 year total shareholder return of 52.58% points to strong recent momentum building around products...

On August 10, 2026, The Accountability Board submitted a shareholder proposal asking Darden Restaurants to adopt and disclose a policy requiring a formal board review and public summary whenever a director in an uncontested election receives support below 80%, following which Darden urged investors to vote against the measure in its September 23, 2026 annual meeting materials. This governance-focused clash arrives just after Darden reported strong fiscal Q4 2026 sales growth and analysts...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Bristol-Myers Squibb stock has delivered a 40.6% 1 year return, while both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to what the business may be worth. The 40.6% gain over the past year suggests sentiment has improved, yet current valuation signals still indicate the market price may be below intrinsic value. Recent FDA accelerated approval for ZENBEXUS can support expectations for future cash flows, while...

US$166b in tariff refunds plus interest is quietly reshaping corporate cash piles, at the same time that fresh trade barriers and a wider US fiscal deficit keep markets on edge. That mix of extra liquidity and higher risk is creating potential winners among financial stocks that sit closest to new corporate cash. This article unpacks the tariff story and highlights three stocks exposed to these refunds that investors may want to keep on their radar. The sample stocks covered below are just a...

Crinetics Pharmaceuticals has delivered a very strong share price run over the past three years, yet its current valuation screens as expensive on market multiples and the broader checks only give it a mixed score. That combination leaves investors weighing a powerful recent return against signals that the stock is not clearly cheap at today’s price of US$84.75. Crinetics Pharmaceuticals has returned 428.0% over the past three years, which sets a high bar for any further gains to be...

Why Hesai Group Stock Is Back In Focus After Q2 Results Hesai Group (HSAI) drew fresh attention after reporting second quarter 2026 results, with higher sales and net income for both the quarter and first half of the year compared with 2025. See our latest analysis for Hesai Group. Hesai Group's earnings release comes after a strong 30 day share price return of 20.47%. However, the share price is still down 24.96% year to date and the 1 year total shareholder return has declined 32.12%, while...

Earlier this month, Health Canada authorized Moderna to begin a Phase I clinical trial of its mRNA Bundibugyo Ebola vaccine candidate, while the U.S. FDA recently approved mFlusiva as the first mRNA flu vaccine for adults aged 50 and older, including accelerated approval for those 65 and above. This pairing of an early-stage Ebola program with full U.S. approval for an mRNA flu shot highlights how Moderna is extending its mRNA platform beyond COVID-19 into both seasonal and outbreak-driven...

Mueller Industries stock has delivered a very large 5 year return, yet its valuation checks now point to a more balanced picture where the Discounted Cash Flow (DCF) intrinsic value estimate looks close to the current share price while market multiples still lean on the cheap side. Mueller Industries has returned about 5.4x over 5 years, which puts extra focus on whether the current price already reflects much of that success. Future cash flow from its manufacturing operations can support...

Molson Coors Beverage (TAP) drew investor attention on 6 August 2026 after reporting softer second quarter and six month earnings, with lower sales and net income compared with the same periods a year earlier. See our latest analysis for Molson Coors Beverage. Molson Coors Beverage shares have come under pressure around the earnings release, with a 1 day share price return of down 4.75% and year to date share price return of down 14.05%. The 3 year total shareholder return of down 28.08%...

With the 30 year U.S. Treasury yield near a 19 year high, income investors are suddenly competing with bonds that pay more for taking less risk. That shift can pressure many stocks, yet it also helps reveal which dividend payers look built to handle tougher financial conditions. This article walks through three stocks from a High Quality Dividend Value screener that appear especially sensitive to this new rate reality. The three stocks below are just a starting sample from this approach,...

Climb Bio, Inc. reported second quarter and six‑month 2026 results, with a net loss of US$13.5 million for the quarter and US$27.22 million for the first half, and higher quarterly loss per share year over year but lower loss per share over six months. The figures highlight a mixed picture for investors, with quarterly losses widening while year‑to‑date losses and loss per share improved compared with 2025. Next, we’ll examine how Climb Bio’s widening quarterly loss but improving...

Karman Holdings earnings, guidance and financing moves in focus Karman Holdings (KRMN) is in focus after second quarter 2026 results, updated full year revenue guidance and a refinancing of its credit facilities that changes the cost of its existing debt structure. See our latest analysis for Karman Holdings. Karman Holdings' latest earnings, raised revenue guidance and credit agreement amendment come after a period where the share price has been volatile. The stock has a 1 month share price...

NextDecade (NEXT) has drawn investor attention after recent share price moves, with the stock closing at $6.95 on 18 August 2026. The company focuses on US liquefied natural gas export and carbon capture projects. See our latest analysis for NextDecade. Against that backdrop, NextDecade’s share price has pulled back in the short term, with a 30 day share price return down 9.51% and a 90 day share price return down 22.52%, while the year to date share price return of 29.18% contrasts with a 1...

Newmark Group, Inc. announced that long-serving CEO Barry Gosin, in the role since 1979, will step down on December 31, 2026, while remaining Chairman of Newmark & Company Real Estate, Inc. to support a smooth leadership transition. This leadership change comes as Newmark shows resilience in commercial real estate, with growing management services, leasing, and capital markets businesses despite broader sector challenges. Next, we’ll examine how Gosin’s planned CEO handover could influence...

SentinelOne (S) is back in focus after Deutsche Bank cut its rating from Buy to Hold, suggesting recent gains already reflect much of the perceived upside ahead of this month’s earnings update. See our latest analysis for SentinelOne. That downgrade comes after a strong run, with SentinelOne’s share price delivering a 49.04% year to date return and a 23.56% 90 day share price return, while the 1 year total shareholder return is 28.28%. If this kind of AI security story has your attention, it...

Studio Mayflower’s launch of Monster Battles on Roblox (RBLX), featuring character work from Pokémon film director Tetsuo Yajima, gives investors fresh content to watch as the platform expands its global entertainment reach. See our latest analysis for Roblox. At a share price of $37.93, Roblox has seen short term momentum fade, with the 30 day share price return down 26.61% and the year to date share price return down 53.14%. However, the 3 year total shareholder return is up 40.69%. If you...

Qualys stock has delivered a 67.1% total return over the past five years, and today an intrinsic value estimate based on a Discounted Cash Flow, or DCF, approach points to upside while market multiples lean the other way. That split, combined with a mixed value score, raises questions about how much of the story is already reflected in the current US$183.31 share price. Over five years, Qualys has returned 67.1%, which suggests the market has already rewarded the company for a meaningful...

Atlassian (NasdaqGS:TEAM) is back in focus after reporting fourth quarter earnings that moved from a prior year net loss to net income, alongside record backlog growth and stronger enterprise customer adoption. See our latest analysis for Atlassian. Atlassian's recent earnings, new AI driven Code Context feature, leadership changes, and a fresh shelf registration have played out against a sharp shift in sentiment, with a 30 day share price return of 69.73% and a 90 day return of 82.8%, even...

Monarch Casino & Resort (MCRI) reported Q2 results with revenue up 4.2% year over year, record second quarter profitability, and near record adjusted EBITDA margins, yet the stock slipped 1.7% after the release. See our latest analysis for Monarch Casino & Resort. At a share price of $123.65, Monarch Casino & Resort has a year to date share price return of 28.75%, while the 1 year total shareholder return of 23.89% and 3 year total shareholder return of 96.18% point to momentum that has...

Airbnb stock has delivered a 44.6% gain over the past three years, yet the valuation picture is mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market multiples suggest the shares are already pricing in a lot of good news. Airbnb is up 44.6% over three years, which puts a sharper focus on whether recent gains are supported by fundamentals or by optimism in the share price. The company’s push into AI driven services and hotels can...

In early August 2026, Remitly Global, Inc. reported strong second-quarter 2026 results, with sales rising to US$495.16 million and net income reaching US$205.91 million, alongside higher earnings per share versus a year earlier. The company also lifted its 2026 revenue outlook to about US$1.98 billion and guided for further net income growth, prompting an analyst rating upgrade and sizeable upward revisions to earnings estimates. We’ll now examine how Remitly’s raised full-year guidance and...

Strategy (NasdaqGS:MSTR) Chair Michael Saylor reiterated a long-term commitment to Bitcoin, urging investors to consider holding the asset for at least four years. Saylor confirmed that Strategy has paused new Bitcoin purchases for the past seven weeks despite recently raising capital through stock sales. The halt in Bitcoin acquisitions marks a change from the company’s previous pattern of frequent purchases and may point to a reassessment of treasury allocation. This shift at Strategy...

Over the last 7 days, the United States market has remained flat, yet it is up 19% over the past year with earnings expected to grow by 17% annually in the coming years. In this context, identifying stocks that are potentially undervalued and exhibit insider action can be a strategic approach for investors looking to capitalize on opportunities within small-cap companies.